Skip to main content
. 2022 May 9;12:824354. doi: 10.3389/fonc.2022.824354

Table 1.

Characteristics of participants in the training cohort and validation cohort.

Variable Training Cohort (n = 50) Validation Cohort (n = 101) p-value
ESCC, n = 23 n (%) Control, n = 27 n (%) ESCC, n = 48 n (%) Control, n = 53 n (%)
Age (years) Mean ± SD 62.3 ± 8.6 58.1 ± 7.7 62.1 ± 8.67 59.2 ± 8.1 p > 0.05
Gender Male (%) 20 (87.0%) 7 (87.5%) 43 (89.6%) 14 (82.4%)
Female (%) 3 (13.0%) 1 (12.5%) 5 (10.4%) 3 (17.6%)
p-value p > 0.05
Smoking Status
Non-smoker (%) 10 (43.5%) 5 (62.5%) 19 (39.6%) 10 (58.8%)
Current or former smoker (%) 13 (56.5%) 3 (37.5%) 29 (60.4%) 6 (35.3%)
Unknown (%) 0 (0%) 0 (0%) 0 (0%) 1 (5.9%)
p-value p < 0.001
Stage
I (%) 7 (30.4%) 14 (29.2%)
II (%) 6 (26.1%) 16 (33.3%)
III (%) 10 (43.5%) 18 (37.5%)
p-value p > 0.05

Only healthy controls from Cancer Hospital, Chinese Academy of Medical Sciences were statistically analyzed in Table 1 in both the training cohort and validation cohort. ESCC: esophagus squamous cell carcinoma.